Valuation: ApicHope Pharmaceutical Group Co., Ltd.

Market Cap 16.33B 2.41B 2.11B 1.95B 1.8B 3.39B 233B 3.45B 23.36B 9.15B 114B 9.06B 8.86B 392B P/E 2026 *
31.4x
P/E 2027 * -158x
Enterprise Value 16.33B 2.41B 2.11B 1.95B 1.8B 3.39B 233B 3.45B 23.36B 9.15B 114B 9.06B 8.86B 392B EV / Sales 2026 *
15.1x
EV / Sales 2027 * 13x
Free-Float
31.84%
Yield 2026 *
-
Yield 2027 * -
1 day-0.74%
1 week-8.43%
Current month-2.36%
1 month+8.92%
3 months-0.49%
6 months-1.52%
Current year+8.49%
1 week 35.73
Extreme 35.73
43.5
1 month 31.37
Extreme 31.37
44.8
Current year 29.31
Extreme 29.31
45.88
1 year 29.31
Extreme 29.31
81.48
3 years 12.74
Extreme 12.74
81.48
5 years 12.74
Extreme 12.74
81.48
10 years 7.58
Extreme 7.5778
81.48
Manager TitleAgeSince
Chief Executive Officer 52 11/11/2015
Director of Finance/CFO 60 11/11/2015
Investor Relations Contact 38 31/12/2020
Director TitleAgeSince
Director/Board Member 70 01/07/2024
Chairman 52 11/11/2015
Director/Board Member 58 11/11/2015
Date Insider Type Main position Quantity % Market Cap.
05/01/26 Buy

Director

4,200 0.0010%
24/11/25 Buy

Director

7,000 0.0017%
01/09/23 Buy 20,000 0.0089%
Change 5-day change 1-year change 3-year change Capi.($)
-0.74%-8.43%-45.76%+32.36% 2.43B
+1.23%+1.08%+15.52%+80.84% 48.15B
-0.23%-1.65%+67.15%+109.36% 35.59B
+1.61%+0.15%-2.75%+39.18% 11.9B
+0.46%-0.16%+17.85%+89.14% 11.85B
-0.37%+2.49%+34.42%+136.73% 9.31B
+3.37%-0.10%+51.64%-4.77% 7.02B
-0.42%-1.32%+16.96%+35.57% 6.91B
-.--%+0.14% - - 6.79B
+0.18%-1.90%+0.63%+211.00% 6.55B
Average +0.51%-1.65%+17.30%+81.04% 14.65B
Weighted average by Cap. +0.63%-0.87%+28.70%+87.71%

Financials

2026 *2027 *
Net sales 1.08B 160M 140M 129M 119M 225M 15.39B 228M 1.55B 606M 7.54B 599M 586M 25.93B 1.26B 186M 163M 151M 138M 262M 17.93B 266M 1.8B 705M 8.78B 698M 683M 30.2B
Net income 526M 77.74M 68.11M 62.94M 57.88M 109M 7.5B 111M 753M 295M 3.67B 292M 286M 12.63B -102M -15.07M -13.21M -12.21M -11.22M -21.21M -1.45B -21.55M -146M -57.19M -712M -56.6M -55.37M -2.45B
Net Debt - -
Logo ApicHope Pharmaceutical Group Co., Ltd.
ApicHope Pharmaceutical Group Co Ltd is a China-based company primarily engaged in the research and development, production and sales of pharmaceuticals. The Company mainly focuses on the fields of pediatrics drug and chronic disease drug, and its product categories cover chemical medicine (including raw materials and preparations), special Chinese patent medicine, biological vaccines and other fields. The Company’s paediatric drugs are used to treat common diseases, such as children's influenza, colds, infectious diseases, functional dyspepsia and others. The Company’s chronic disease drugs are used for treatment of cardiovascular and cerebrovascular diseases, kidney diseases, digestive system diseases, liver diseases and other diseases. The Company’s main products include Fuganlin oral liquid, clindamycin hydrochloride palmitate dispersible tablets and other products. The Company mainly conducts its business in the domestic market.
Employees
1,294
Date Price Change Volume
20/07/26 CN¥36.40 -0.74% 13,121,235
17/07/26 CN¥36.67 -12.38% 21,128,034
16/07/26 CN¥41.85 +2.27% 23,962,701
15/07/26 CN¥40.92 +0.52% 27,558,495
14/07/26 CN¥40.71 +3.43% 19,727,349

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 300723 Stock